Towards Healthcare
Radiation Oncology Market to Promote USD 32.78 Bn by 2034

Radiation Oncology Market 2025 Expansion Insights

According to market projections, the radiation oncology sector is expected to grow from USD 11.17 billion in 2024 to USD 32.78 billion by 2034, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the global market. A robust healthcare infrastructure and favorable regulatory policies contribute to North America’s dominance.

  • Last Updated: 15 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The radiation oncology market stands at USD 12.45 billion in 2025 and is expected to reach USD 32.78 billion by 2034, growing at a CAGR of 11.44% from 2024 to 2034.

North America is leading the radiation oncology market due to the availability of a robust healthcare infrastructure, the presence of key players, and favorable regulatory policies.

Some key players include GE Healthcare, Elekta AB, and Becton, Dickinson and Company.

Radiotherapy can be used at any stage of cancer, from early-stage and pre-surgery to advanced stage, depending on the purpose.

Some possible side effects of radiation therapy include fertility problems, heart problems, lung problems, changes in skin color, and mental or emotional problems.

Australian Government Department of Health, Disability, and Aging, Centers for Medicare & Medicaid Services, mea.gov.in, National Cancer Institute, Press Information Bureau